These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 17001081)
1. Identification of an hexapeptide that binds to a surface pocket in cyclin A and inhibits the catalytic activity of the complex cyclin-dependent kinase 2-cyclin A. Canela N; Orzáez M; Fucho R; Mateo F; Gutierrez R; Pineda-Lucena A; Bachs O; Pérez-Payá E J Biol Chem; 2006 Nov; 281(47):35942-53. PubMed ID: 17001081 [TBL] [Abstract][Full Text] [Related]
2. Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors. Nandha Premnath P; Craig S; McInnes C J Vis Exp; 2015 Oct; (105):e52441. PubMed ID: 26554946 [TBL] [Abstract][Full Text] [Related]
3. Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation. Gondeau C; Gerbal-Chaloin S; Bello P; Aldrian-Herrada G; Morris MC; Divita G J Biol Chem; 2005 Apr; 280(14):13793-800. PubMed ID: 15649889 [TBL] [Abstract][Full Text] [Related]
4. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division. Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360 [TBL] [Abstract][Full Text] [Related]
5. Insights on Structural Characteristics and Ligand Binding Mechanisms of CDK2. Li Y; Zhang J; Gao W; Zhang L; Pan Y; Zhang S; Wang Y Int J Mol Sci; 2015 Apr; 16(5):9314-40. PubMed ID: 25918937 [TBL] [Abstract][Full Text] [Related]
6. The role of the phospho-CDK2/cyclin A recruitment site in substrate recognition. Cheng KY; Noble ME; Skamnaki V; Brown NR; Lowe ED; Kontogiannis L; Shen K; Cole PA; Siligardi G; Johnson LN J Biol Chem; 2006 Aug; 281(32):23167-79. PubMed ID: 16707497 [TBL] [Abstract][Full Text] [Related]
7. Structural basis for the ORC1-Cyclin A association. Wang B; Song J Protein Sci; 2019 Sep; 28(9):1727-1733. PubMed ID: 31309634 [TBL] [Abstract][Full Text] [Related]
8. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Brown NR; Noble ME; Endicott JA; Johnson LN Nat Cell Biol; 1999 Nov; 1(7):438-43. PubMed ID: 10559988 [TBL] [Abstract][Full Text] [Related]
9. Alternative binding modes of an inhibitor to two different kinases. De Moliner E; Brown NR; Johnson LN Eur J Biochem; 2003 Aug; 270(15):3174-81. PubMed ID: 12869192 [TBL] [Abstract][Full Text] [Related]
10. Selective anticancer activity of a hexapeptide with sequence homology to a non-kinase domain of Cyclin Dependent Kinase 4. Warenius HM; Kilburn JD; Essex JW; Maurer RI; Blaydes JP; Agarwala U; Seabra LA Mol Cancer; 2011 Jun; 10():72. PubMed ID: 21668989 [TBL] [Abstract][Full Text] [Related]
11. Meriolins (3-(pyrimidin-4-yl)-7-azaindoles): synthesis, kinase inhibitory activity, cellular effects, and structure of a CDK2/cyclin A/meriolin complex. Echalier A; Bettayeb K; Ferandin Y; Lozach O; Clément M; Valette A; Liger F; Marquet B; Morris JC; Endicott JA; Joseph B; Meijer L J Med Chem; 2008 Feb; 51(4):737-51. PubMed ID: 18232649 [TBL] [Abstract][Full Text] [Related]
12. Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects. Mettey Y; Gompel M; Thomas V; Garnier M; Leost M; Ceballos-Picot I; Noble M; Endicott J; Vierfond JM; Meijer L J Med Chem; 2003 Jan; 46(2):222-36. PubMed ID: 12519061 [TBL] [Abstract][Full Text] [Related]
13. The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death. Ferguson M; Luciani MG; Finlan L; Rankin EM; Ibbotson S; Fersht A; Hupp TR Cell Cycle; 2004 Jan; 3(1):80-9. PubMed ID: 14657672 [TBL] [Abstract][Full Text] [Related]
14. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes. Sarcevic B; Lilischkis R; Sutherland RL J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125 [TBL] [Abstract][Full Text] [Related]
15. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A. Lowe ED; Tews I; Cheng KY; Brown NR; Gul S; Noble ME; Gamblin SJ; Johnson LN Biochemistry; 2002 Dec; 41(52):15625-34. PubMed ID: 12501191 [TBL] [Abstract][Full Text] [Related]
16. The cyclin-dependent kinases cdk2 and cdk5 act by a random, anticooperative kinetic mechanism. Clare PM; Poorman RA; Kelley LC; Watenpaugh KD; Bannow CA; Leach KL J Biol Chem; 2001 Dec; 276(51):48292-9. PubMed ID: 11604388 [TBL] [Abstract][Full Text] [Related]
17. Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. Jin YH; Yoo KJ; Lee YH; Lee SK J Biol Chem; 2000 Sep; 275(39):30256-63. PubMed ID: 10884382 [TBL] [Abstract][Full Text] [Related]
18. ATP-noncompetitive inhibitors of CDK-cyclin complexes. Orzáez M; Gortat A; Mondragón L; Bachs O; Pérez-Payá E ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815 [TBL] [Abstract][Full Text] [Related]
19. Activation mechanism of CDK2: role of cyclin binding versus phosphorylation. Stevenson LM; Deal MS; Hagopian JC; Lew J Biochemistry; 2002 Jul; 41(26):8528-34. PubMed ID: 12081504 [TBL] [Abstract][Full Text] [Related]
20. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes. Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]